Xiaoxiang Peng

9PUBLICATIONS
9CO-AUTHORS
Molecular targetsPredictive and prognostic markersAutoimmunityProteins and peptidesGlycoconjugates
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jul 16, 2025
Blocking or knockdown of P2X7 receptor inhibits invasion and migration of mouse breast cancer cells via PI3K/Akt/GSK-3β pathways and EMT.

Ronglan Zhao, Yanwen Xue, Yahui Cao

|Jul 03, 2025
P2X7R: A Critical Regulator and Potential Therapeutic Target for Glioma.

Meng Yan, Ronglan Zhao, Yanwen Xue

|Mar 01, 2023
Purinergic P2X7R as a potential target for pancreatic cancer.

Qingqing Yu, Xin Wang, Xinyu Li

|Nov 20, 2022
Research progress on the P2X7 receptor in liver injury and hepatocellular carcinoma.

Xinyu Li, Xue Bai, Yiqing Tang

|Jul 07, 2022
Research Progress in the Relationship Between P2X7R and Cervical Cancer.

Yiqing Tang, Cuicui Qiao, Qianqian Li

|Sep 06, 2020
The P2X7 purinergic receptor: a potential therapeutic target for lung cancer.

Qianqian Li, Xiaodi Zhu, Wei Song

Pageof 2